HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James N Ingle Selected Research

Melanoma (Melanoma, Malignant)

6/2007A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.
8/2006Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma.
8/2006Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.
1/2006Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James N Ingle Research Topics

Disease

189Breast Neoplasms (Breast Cancer)
05/2024 - 01/2002
97Neoplasms (Cancer)
03/2024 - 02/2002
15Triple Negative Breast Neoplasms
06/2022 - 01/2013
11Neoplasm Metastasis (Metastasis)
05/2021 - 06/2002
8Disease Progression
01/2023 - 09/2003
7Osteoporosis
07/2017 - 11/2003
5Pain (Aches)
01/2018 - 11/2003
4Bone Fractures (Bone Fracture)
07/2016 - 09/2005
4Noninfiltrating Intraductal Carcinoma (DCIS)
11/2015 - 06/2002
4Melanoma (Melanoma, Malignant)
06/2007 - 01/2006
3Neutropenia
01/2023 - 12/2005
3T-Cell Leukemia (Leukemia, T Cell)
01/2018 - 03/2012
3Arthralgia (Joint Pain)
01/2018 - 11/2003
2Pathologic Complete Response
01/2018 - 01/2017
2Endometrial Neoplasms (Endometrial Cancer)
10/2017 - 08/2013
2Metabolic Bone Diseases (Osteopenia)
07/2017 - 04/2013
2Drug-Related Side Effects and Adverse Reactions
01/2017 - 03/2012
2Inflammation (Inflammations)
01/2017 - 01/2010
2Musculoskeletal Pain
03/2016 - 03/2012
2Bone Resorption
01/2014 - 08/2006
2Uterine Hemorrhage (Uterine Bleeding)
04/2013 - 11/2003
2Colorectal Neoplasms (Colorectal Cancer)
01/2013 - 02/2006
2Pleural Effusion (Pleural Effusions)
06/2012 - 08/2010

Drug/Important Bio-Agent (IBA)

66TamoxifenFDA LinkGeneric
01/2023 - 01/2002
44Aromatase InhibitorsIBA
02/2022 - 08/2002
40Estrogen ReceptorsIBA
01/2023 - 11/2002
37Hormones (Hormone)IBA
01/2023 - 08/2002
27Estrogens (Estrogen)FDA Link
05/2024 - 01/2002
25Anastrozole (Arimidex)FDA LinkGeneric
05/2024 - 08/2002
25Letrozole (Femara)FDA LinkGeneric
02/2022 - 09/2003
23exemestane (Aromasin)FDA Link
01/2023 - 09/2003
15Biomarkers (Surrogate Marker)IBA
03/2024 - 06/2007
144-hydroxy-N-desmethyltamoxifenIBA
12/2023 - 12/2005
14Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2018 - 12/2005
14Doxorubicin (Adriamycin)FDA LinkGeneric
09/2015 - 02/2003
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 03/2003
12Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2002
12DNA (Deoxyribonucleic Acid)IBA
01/2023 - 10/2009
12Trastuzumab (Herceptin)FDA Link
01/2021 - 06/2002
12Paclitaxel (Taxol)FDA LinkGeneric
09/2015 - 02/2003
10Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 11/2002
9Selective Estrogen Receptor Modulators (SERM)IBA
10/2017 - 08/2007
8Aromatase (CYP19)IBA
01/2020 - 11/2004
8Estrogen Receptor alphaIBA
01/2018 - 08/2007
7Estradiol (Delestrogen)FDA LinkGeneric
05/2024 - 08/2009
7AnthracyclinesIBA
01/2021 - 07/2004
7ErbB Receptors (EGF Receptor)IBA
12/2011 - 09/2004
6Fulvestrant (Faslodex)FDA Link
01/2023 - 03/2006
6Phenobarbital (Luminal)FDA Link
06/2022 - 09/2014
6Diphosphonates (Bisphosphonates)IBA
05/2021 - 02/2002
6CytokinesIBA
01/2018 - 06/2002
6EnzymesIBA
11/2011 - 01/2007
5Aurora Kinase AIBA
01/2023 - 10/2017
5ParaffinIBA
12/2014 - 12/2005
4EstroneFDA Link
05/2024 - 01/2010
4Androgen Receptors (Androgen Receptor)IBA
01/2023 - 10/2013
4RNA (Ribonucleic Acid)IBA
10/2021 - 07/2004
4taxaneIBA
01/2021 - 07/2004
4P-2 (P 2)IBA
10/2017 - 07/2013
4Raloxifene Hydrochloride (Evista)FDA Link
01/2015 - 06/2011
4Transforming Growth Factor beta (TGF-beta)IBA
07/2011 - 06/2002
4VaccinesIBA
08/2010 - 08/2006
3LigandsIBA
01/2024 - 06/2002
3MLN 8237IBA
01/2023 - 10/2017
3Estrogen Receptor betaIBA
02/2022 - 03/2011
3HLA-DR Antigens (HLA-DR)IBA
10/2021 - 01/2010
3Zoledronic Acid (Zometa)FDA Link
05/2021 - 07/2010
3Docetaxel (Taxotere)FDA Link
01/2021 - 01/2005
3AntibodiesIBA
01/2020 - 08/2011
3afimoxifene (hydroxytamoxifen)IBA
06/2019 - 03/2009
3human ERBB2 proteinIBA
11/2017 - 01/2010
3Formaldehyde (Formol)FDA Link
12/2014 - 08/2011
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2013 - 12/2005
3DNA AdductsIBA
10/2012 - 05/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2012 - 06/2002
3Estrogen Receptor Modulators (Antiestrogen)IBA
03/2009 - 11/2004
3Messenger RNA (mRNA)IBA
08/2006 - 06/2002
3Carboplatin (JM8)FDA LinkGeneric
01/2006 - 01/2005
2Clodronic Acid (Clodronate)IBA
05/2021 - 01/2020
2Ibandronic Acid (Boniva)FDA Link
05/2021 - 01/2020
2Long Noncoding RNAIBA
01/2019 - 12/2016
2olaparibIBA
12/2018 - 01/2017
2Cytochrome P-450 CYP2D6 InhibitorsIBA
01/2018 - 11/2011
2Bevacizumab (Avastin)FDA Link
01/2018 - 01/2018
2ClaudinsIBA
01/2018 - 07/2011
2Cell-Free Nucleic AcidsIBA
10/2017 - 03/2017
2Steroid Receptors (Steroid Receptor)IBA
01/2017 - 12/2006
2Tumor Biomarkers (Tumor Markers)IBA
01/2016 - 05/2005
2OsteoprotegerinIBA
10/2014 - 06/2002
2Cyclin EIBA
09/2014 - 12/2006
2Phosphotransferases (Kinase)IBA
09/2014 - 01/2014

Therapy/Procedure

91Therapeutics
03/2024 - 01/2002
30Drug Therapy (Chemotherapy)
01/2023 - 02/2003
14Adjuvant Chemotherapy
02/2021 - 03/2003
10Neoadjuvant Therapy
06/2022 - 01/2010
3Chemoprevention
01/2020 - 11/2011
3Aftercare (After-Treatment)
12/2006 - 01/2005
2Radiotherapy
02/2021 - 01/2020
2Precision Medicine
12/2018 - 06/2013
2Segmental Mastectomy (Lumpectomy)
11/2015 - 05/2007